Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
exemestane, Quantity: 25 mg
Pfizer Australia Pty Ltd
Tablet, sugar coated
Excipient Ingredients: silicon dioxide; crospovidone; hypromellose; magnesium carbonate hydrate; mannitol; microcrystalline cellulose; methyl hydroxybenzoate; macrogol 6000; polysorbate 80; polyvinyl alcohol; sodium starch glycollate; sucrose; titanium dioxide; cetyl esters wax; purified talc; Carnauba Wax; Shellac; iron oxide black; magnesium stearate; purified water; sorbic acid; dimeticone 100; dimeticonol; benzoic acid
Oral
30 Tablets, 15 Tablets, 90 Tablets
(S4) Prescription Only Medicine
AROMASIN is indicated for the sequential adjuvant treatment of estrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy.,AROMASIN is indicated for the treatment of estrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-estrogen therapy.
Visual Identification: Round, biconvex, off white to slightly greyish tablets, about 6mm in diameter. The tablets are printed on one side "7663" in black.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2000-11-30
AROMASIN ® _Exemestane_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about AROMASIN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking AROMASIN against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT AROMASIN IS USED FOR AROMASIN is used to treat breast cancer in women who no longer have their menstrual periods, either naturally due to their age (after menopause) or because they have had their ovaries surgically removed. AROMASIN is used to reduce the risk of recurrence or spreading of the breast cancer. It is also used when the cancer has not responded or has returned after treatment with another medicine or medicines. _HOW AROMASIN WORKS_ AROMASIN is an aromatase inactivator. It works by significantly reducing the supply of oestrogen to cancer cells. This stops the growth of those cancer cells which need oestrogen, a natural female sex hormone, to grow. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY AROMASIN HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another purpose. AROMASIN is only available with a doctor's prescription. It is not addictive. BEFORE YOU TAKE AROMASIN _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE AROMASIN AND TALK TO YOUR DOCTOR IF YOU THINK YOU MAY HAVE AN ALLERGY TO: • exemestane, the active ingredient in AROMASIN • any of the other ingredients in AROMASIN listed at the end of this leaflet. Symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing; swelling of the face, lips, tongue or other parts of the body; rash, itching or hives on the skin. DO NOT TAKE AROMASIN IF YOU ARE PREGNANT OR INTEND TO BECOME PREGNANT. AROMASIN may affect your developing baby if you take it during pregnancy. DO NO Прочитать полный документ
Version: pfparomt11121 Supersedes: pfparomt10919 Page 1 of 17 AUSTRALIAN PRODUCT INFORMATION - AROMASIN ® (EXEMESTANE) TABLETS 1. NAME OF THE MEDICINE Exemestane 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 25 mg tablet contains 25 mg exemestane EXCIPIENTS WITH KNOWN EFFECT Each tablet contains 30.2 mg of sucrose and 0.003 mg of methyl hydroxybenzoate. For the full list of excipients, see Section 6.1, List of Excipients. 3. PHARMACEUTICAL FORM AROMASIN tablets are sugar-coated tablets for oral administration. The tablets are imprinted “7663” on one side with black printing ink. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS AROMASIN is indicated for the sequential adjuvant treatment of estrogen receptor-positive early breast cancer in postmenopausal women who have received prior adjuvant tamoxifen therapy. AROMASIN is indicated for the treatment of estrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-estrogen therapy. 4.2 DOSE AND METHOD OF ADMINISTRATION ADULTS The recommended dose of AROMASIN in adults is one 25 mg tablet taken once daily, preferably after a meal. In patients with early breast cancer, treatment should continue until completion of five years adjuvant hormonal therapy, or until tumour relapse occurs. In patients with advanced breast cancer, treatment with AROMASIN should continue until tumour progression is evident. Version: pfparomt11121 Supersedes: pfparomt10919 Page 2 of 17 No dose adjustments are required for patients with hepatic or renal insufficiency. PAEDIATRIC USE Not recommended for use in children. 4.3 CONTRAINDICATIONS AROMASIN tablets are contraindicated in pregnant or lactating women and in patients with a known hypersensitivity to the medicine or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Check the following before use. Because of its mode of action, AROMASIN should not be administered to women with premenopausal endocrine status. Whenever clinic Прочитать полный документ